WNX
Director Trades
| Date | Director | Value |
|---|---|---|
| 4/3/25 | J. Yeh | $1,300,000 |
| 4/3/25 | Z. Bozinovski | $120,000 |
| 4/3/25 | G. Karafotias | $44,242 |
Company News
Wellnex Life directors commit $1.5m to current entitlement offer
The directors of diverse consumer healthcare business Wellnex Life (ASX: WNX) have committed to subscribe for a minimum of $1.5 million as part of the company’s current entitlement offer. The offer is part of the company’s growth strategy, which includes a proposed listing on the AIM market of the London Stock Exchange. Funds raised and […]
Wellnex Life secures $14.3m for dual listing on London Stock Exchange
Wellnex Life (ASX: WNX) has secured conditional binding commitments to raise $14.3 million to fund its proposed dual listing on the London Stock Exchange’s (LSE) Alternative Investment Market (AIM) next month. The company has received interest from UK and Australian institutions and sophisticated investors for a non-renounceable pro-rata entitlement offer of one new Wellnex share […]
Wellnex Life raises $9m ahead of proposed London Stock Exchange AIM listing
Healthcare business Wellnex Life (ASX: WNX) has received initial conditional binding commitments of $9 million to support its proposed dual listing on the AIM sub-market of the London Stock Exchange (LSE). After receiving significant interest from UK-based institutions and sophisticated investors, the company launched the 1:1 non-renounceable entitlement offer it had previously announced earlier this […]
Wellnex Life expands global reach with UK market entry and new product approval
Wellnex Life (ASX: WNX) has achieved another breakthrough in its expansion plans with a new market authorisation (MA) for its liquid paracetamol plus caffeine soft gel. The MA comes after Wellnex made a successful submission to Australia’s Therapeutic Goods Administration for the latest addition to its product range. The company had previously been granted MAs […]
Wellnex Life reports record $3m in monthly sales as it pursues dual listing on LSE
Wellnex Life (ASX: WNX) has reported record sales of $3 million per month for November and December 2024, with 56% of the revenue coming from its own high-margin brands. The total of $11.94m in sales for the first half of the financial year 2025 represented an increase of 112% against the $5.63m recorded in the previous […]
Wellnex Life on track to meet guidance as sales continue to grow
Consumer healthcare business Wellnex Life (ASX: WNX) has announced it is on track to meet its guidance of $29 million for the 2023 financial year, up 55% on the previous year. This increase has primarily been the result of growth in both the company’s brand offering and its intellectual property (IP) licencing. Over the last […]
Wellnex Life to launch medicinal cannabis products into emerging SAS-B market with Chemist Warehouse
Customer-focused healthcare company Wellnex Life (ASX: WNX) has unveiled plans to launch medicinal cannabis products into Australia’s rapidly emerging Special Access Scheme Category B (SAS-B) market. The company has added Chemist Warehouse to its joint venture with OneLife Botanicals to conduct the launch, which will introduce five new co-branded medicinal cannabis products before year-end. The […]
Wellnex Life delivers first batch of Pharmacy Own products to exclusive distributor
Health and wellness company Wellnex Life (ASX: WNX) has delivered the first batch of its Pharmacy Own over-the-counter (OTC) products to exclusive distributor Clifford Hallam Healthcare. The brand is wholly-owned by Wellnex and is expected to deliver significant sales and enhanced margins to the company. Clifford Hallam Healthcare is an Australian pharmaceutical and medical consumables […]
Wellnex Life launches online retail platform targeting active lifestyle B2C market
Wellnex Life (ASX: WNX) has launched a one-stop platform and brand known as TheSet.Co which will sell products directly to consumers in the large and growing online health and wellness market. The site provides Wellnex with its first direct business-to-consumer (B2C) retail channel and offers an initial range of 19 “hardworking and functional” self-care products […]
Wellnex Life tops-up bank balance with $6m to fund over-the-counter medicinal cannabis product plans
Wellnex Life (ASX: WNX) has raised almost $6 million via a capital raising and strategic investment to pursue its strategy of offering one of Australia’s first over-the-counter medicinal cannabis products – along with a strong pipeline of other product launches. The company set out to raise $2 million via a share purchase plan last month, […]
